Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3… Grant US-10517866-B2 United States of America 31 Dec 2019
Compositions of matter for treatment of ophthalmic conditions by selectively removing… Grant US-10478432-B2 United States of America 19 Nov 2019
Methods and compositions for killing senescent cells and for treating senescence-associated… Grant US-10413542-B2 United States of America 17 Sep 2019
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by… Grant US-10328073-B2 United States of America 25 Jun 2019
Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic… Grant US-10328058-B2 United States of America 25 Jun 2019
Treating pulmonary conditions by selectively removing senescent cells from the lung using… Grant US-10258618-B2 United States of America 16 Apr 2019
Method of optimizing conditions for selectively removing a plurality of senescent cells… Grant US-10213426-B2 United States of America 26 Feb 2019
Treatment of ophthalmic conditions by selectively removing senescent cells from the eye Grant US-10010546-B2 United States of America 03 Jul 2018
Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 Grant US-9993472-B2 United States of America 12 Jun 2018
Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions… Grant US-9980962-B2 United States of America 29 May 2018
Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline Grant US-9855266-B2 United States of America 02 Jan 2018
Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent… Grant US-9849128-B2 United States of America 26 Dec 2017